FDA — authorised 31 December 1993
- Application: NDA019304
- Marketing authorisation holder: ABBVIE
- Local brand name: LIPIDIL
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised fenofibrate and tibolone on 31 December 1993
Yes. FDA authorised it on 31 December 1993.
ABBVIE holds the US marketing authorisation.